Immuno-Oncology and Technology
SJR1.883
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 1.883 | Q1 | 94.7% | |
| 2024 | — | — | 2.430 | Q1 | 96.7% | |
| 2023 | — | — | 1.987 | Q1 | 95.5% | |
| 2022 | — | — | 0.691 | Q3 | 76.4% | |
| 2021 | — | — | — | 5.2% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2590-0188
country
UScoverage
2019-2026